Safety of Inpatient Health Care
A retrospective cohort study shows that adverse events — most commonly caused by drugs — occurred in nearly 1 in 4 admissions to 11 Massachusetts
A retrospective cohort study shows that adverse events — most commonly caused by drugs — occurred in nearly 1 in 4 admissions to 11 Massachusetts
Older adults taking chlorthalidone for hypertension did not have a lower occurrence of major cardiovascular events or non–cancer-related deaths than those on hydrochlorothiazide in the
Patients under treatment of diabetes with certain glucose-lowering agents have lower rates of adverse outcomes from COVID-19, according to a systematic review and network meta-analysis.
The FDA yesterday issued Safety and Effectiveness of Certain Naloxone Hydrochloride Drug Products for Nonprescription Use, a document that may help facilitate the development and approval
In a cohort study of pregnant persons with mild-to-moderate COVID-19, adverse events rarely occurred in those who received monoclonal antibodies (mAb), and obstetric safety outcomes
Results of a phase 2 trial support the conduct of larger and longer studies of Q-122 in women with vasomotor symptoms following treatment for breast
A risk-prediction model using common clinical measures can categorize a person’s chances of having a serious fall as high or low after at least 1
Healthcare professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse
A study from Australia “adds to the evidence” that daily low-dose aspirin “provides little favorable benefit in a healthy, White older adult population.” Aspirin failed
In a special issue on healthcare access and reproductive rights, JAMA publishes research and several opinion articles that examine the effects on healthcare of the